University of Miami
Human Subject Research Office
Non Human SubjectResearch Determination Application
INSTRUCTIONS: Please type directly on this form. You can expand the document if you need more space. If your research involves a survey or questionnaire, please attach it to this completed form.
Completed forms (with all required signatures) may be sent to the HSRO by FAX (305-243-3328) or by email to an IRB Regulatory Analyst. If you have any questions, call the HSRO at (305) 243-3195
To: HUMAN SUBJECTS RESEARCH OFFICE, JMT-East, Suite 1002
Principal Investigator: Telephone Number:University Title: Department:
Email Address:Campus:
Mailing Address: Locator Code:
Title:
The Principal investigator is an employee of: UM JHS
If neither, please explain:
If applicable, list your non-UM/JHS Collaborating Investigator(s). NA
Name Institution Address Tel. # FAX #
Proposed start date of your activity Proposed completion date
Provide a lay summary of the purpose of the study.
Describe all study procedures you intend to perform.(please use lay terms):
A. Quality Improvement activities
Yes No Is the activity to assess or improve a process, program, or system OR to improve
performance as judged by established/ accepted standards.
Describe what is being assessed :
If “yes” Describe how the knowledge sought will benefit the process/program/system.
B. DHHS Determination of “Research”
1. Yes NoIs the activity an investigation? (Investigation: A searching inquiry for facts: detailed or careful
examination )
2. Yes NoIs the investigation systematic? (Systematic: Having or involving a system, method, or plan.)
3. Yes NoIs the investigation designed to develop or contribute to generalizable knowledge?(Designed: observable behaviors used to develop or contribute to knowledge. Develop: to form the basis for a future contribution. Contribute: to result in. Knowledge: truths, facts, information.Generalizable: Universally or widely applicable.)
C. DHHS Determination of “Human Subjects”
1. Yes NoIs the data/sample you are planning to obtain about living individuals?
What kind of human samples (e.g., tissue, blood) or data (e.g., private information,
responses to questionnaires) will be involved in your research?
a) Indicate the number of participants data/samples you are planning to include:
b)Yes NoIs this a case report?
c)Yes NoIf this is a case report, the patients are those treated by the clinician preparing
the report
2.Where are the subjects of this research activity located?
3. Yes No If human subjects are located elsewhere (not at UM/JHS), will you have direct
contact or intervention with them? (Examples: as subject's physician; in obtaining
samples directly from the subject; by interviewing the subject?)
4. Samples or Data Handling. (check appropriate item(s))
Yes No Will be collecting samples or Data?
Yes NoWill be receiving samples or Data?
Yes NoWill be sending samples or Data?
5. Do the samples or data:
(a) Yes NoAlready exist? Or
(b) Yes NoAre they being collected for the express purpose of this study?
If “yes,” please describe:
(c) Yes NoOr a combination of (a) and (b)?
Please describe:
6. If the samples, data, do not come from an IRB approved protocol, do they come
from:
(a) Yes NoRepository
(b) Yes No Pathological waste
(c) Yes No Autopsy material
(d) Yes No Publicly available source
(e) Other
7. Please check the box(es) that apply(ies) to the samples/data that you will receive.
(a) Samples and/or data will be anonymized/unlinked. (The samples/data cannot
be linked to individual subjects by you or your collaborators at other sites.)
(b) Samples and/or data will be coded, however that code cannot be used by
either the sender or the receiver to identify specific individuals.
(c) Samples and/or data will be coded so that the provider of the samples/data can link
them to specific individuals but the receiver will not be able to do so.
8. What role will you have in this research project? (Check all that apply)
Analyze samples/data only.
Consultant/advisor to collaborator(s) listed above.
Author of the protocolthat is being implemented by your collaborating
investigator (identified in question #2).
Co-authorship on publication(s)/ manuscript(s) pertaining to this research.
You or collaborator holds an IND for this research.
Decisional authority over the design or implementation of the research at the IRB
approved site? If so, please explain.
If other (describe your role in this research).
9. Has the research activity that you are proposing in this form been approved by
an Institutional Review Board (IRB) elsewhere?
No IRB review of the research activity described in question #1 above has
taken place.
Yes, the research activity has been reviewed by the following IRB (s) (Please
provide the following information for each IRB):
Name of institution that provided the review
Address of reviewing institution
Name of PI for the IRB approved protocol
Title of IRB approved protocol and protocol #
Federal Wide Assurance (FWA) number**
(**An FWA is a contract between the U.S. Department of Health and Human Services (DHHS) and an entity receiving DHHS funds to conduct clinical research that the latter will follow ethical guidelines and federal regulations for the protection of human subjects.
10. Will you send results back to the provider(s))?
(a)No, I will not send results back to the provider(s).
(b)Yes, I will send aggregate results to the provider(s).
(c) Yes, I will send results to the provider(s) that are linked to identifiable individuals.
Yes No If yes, does the provider intend to link your data to identifiable individuals?
D. FDA Determination of Human Subject Research
1. Yes NoIs the activity an experiment to evaluate the safety or effectiveness of a drug or
device?
2. Yes NoDoes the activity involve one or more of the following test articles?
* Foods or dietary supplements that include a nutrient content claim or a health claim
* Infant formulas
* Food and color additives
* Drugs for human use
* Medical devices for human use
* Biological products for human use
* Electronic products
- Yes NoWill the study involve using test articles with one or more human participants?
- Yes NoIs the study being done as part of an IND or IDE submission?
- Yes NoCould the data be submitted to the FDA or held for inspection by the FDA?
CONFLICT OF INTEREST
1. Yes No NAHave conflicts of interest by the research personnel, if any, been resolved?
______
Signature of Principal InvestigatorDate
I hereby confirm that I have read this application and my signature denotes departmental/unit approval of this project. To the best of my knowledge, the information in the application relating to members of my department is correct.
______
Print Name of Department Head
______
SIGNATURE of Department HeadDate
1
Non-Human / Non-Research Determination Application
Version 050912